CVE-2022-30277

MITRE NVD CVE.ORG Print: PDF PDF

Summary

CVECVE-2022-30277
StatePUBLIC
Assigner[email protected]
Source PriorityCVE Program / NVD first with legacy fallback
Published2022-06-02 14:15:00 UTC
Updated2022-06-10 02:14:00 UTC
DescriptionBD Synapsys™, versions 4.20, 4.20 SR1, and 4.30, contain an insufficient session expiration vulnerability. If exploited, threat actors may be able to access, modify or delete sensitive information, including electronic protected health information (ePHI), protected health information (PHI) and personally identifiable information (PII).

Risk And Classification

Problem Types: CWE-613

NVD Known Affected Configurations (CPE 2.3)

TypeVendorProductVersionUpdateEditionLanguage
Application Bd Synapsys 4.20 - All All
Application Bd Synapsys 4.20 sr1 All All
Application Bd Synapsys 4.30 All All All

References

ReferenceSourceLinkTags
BD Synapsys<sup>™</sup>– Insufficient Session Expiration CONFIRM cybersecurity.bd.com
CVE Program record CVE.ORG www.cve.org canonical
NVD vulnerability detail NVD nvd.nist.gov canonical, analysis
© CVE.report 2026 |

Use of this information constitutes acceptance for use in an AS IS condition. There are NO warranties, implied or otherwise, with regard to this information or its use. Any use of this information is at the user's risk. It is the responsibility of user to evaluate the accuracy, completeness or usefulness of any information, opinion, advice or other content. EACH USER WILL BE SOLELY RESPONSIBLE FOR ANY consequences of his or her direct or indirect use of this web site. ALL WARRANTIES OF ANY KIND ARE EXPRESSLY DISCLAIMED. This site will NOT BE LIABLE FOR ANY DIRECT, INDIRECT or any other kind of loss.

CVE, CWE, and OVAL are registred trademarks of The MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. This site includes MITRE data granted under the following license.

CVE.report and Source URL Uptime Status status.cve.report